162 related articles for article (PubMed ID: 30990074)
1. Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma.
Palumbo C; Cyr SJ; Mazzone E; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Kapoor A; Antonelli A; Karakiewicz PI
J Endourol; 2019 Jul; 33(7):606-613. PubMed ID: 30990074
[No Abstract] [Full Text] [Related]
2. Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.
Palumbo C; Mistretta FA; Knipper S; Mazzone E; Pecoraro A; Tian Z; Perrotte P; Antonelli A; Montorsi F; Shariat SF; Saad F; Simeone C; Briganti A; Lavallee LT; Karakiewicz PI
Minerva Urol Nefrol; 2020 Jun; 72(3):350-359. PubMed ID: 31487976
[TBL] [Abstract][Full Text] [Related]
3. Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer.
Pecoraro A; Palumbo C; Knipper S; Mistretta FA; Tian Z; Shariat SF; Saad F; Briganti A; Fiori C; Porpiglia F; Karakiewicz PI
J Urol; 2019 Dec; 202(6):1120-1126. PubMed ID: 31347950
[TBL] [Abstract][Full Text] [Related]
4. Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy.
Sorce G; Hoeh B; Hohenhorst L; Panunzio A; Tappero S; Tian Z; Kokorovic A; Larcher A; Capitanio U; Tilki D; Terrone C; Chun FKH; Antonelli A; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
Eur Urol Focus; 2023 Jan; 9(1):125-132. PubMed ID: 35918270
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
Marchioni M; Preisser F; Bandini M; Nazzani S; Tian Z; Kapoor A; Cindolo L; Abdollah F; Tilki D; Briganti A; Montorsi F; Shariat SF; Schips L; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
[TBL] [Abstract][Full Text] [Related]
6. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Cryoablation with Heat-Based Thermal Ablation for Treatment of Clinical T1a Renal Cell Carcinoma: A National Cancer Database Study.
Wu J; Chang J; Bai HX; Su C; Zhang PJ; Karakousis G; Reddy S; Hunt S; Soulen MC; Stavropoulos SW; Zhang Z
J Vasc Interv Radiol; 2019 Jul; 30(7):1027-1033.e3. PubMed ID: 31176590
[TBL] [Abstract][Full Text] [Related]
8. Partial nephrectomy vs cryoablation for T1a renal cell carcinoma: A comparison of survival benefit stratified by tumour size.
Liao X; Qiu S; Wang W; Zheng X; Jin K; Zhang S; Bao Y; Yang L; Wei Q
Cancer Epidemiol; 2019 Apr; 59():221-226. PubMed ID: 30836219
[TBL] [Abstract][Full Text] [Related]
9. Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.
Mazzone E; Nazzani S; Preisser F; Tian Z; Marchioni M; Bandini M; Capitanio U; Kapoor A; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; I Karakiewicz P
Cancer Epidemiol; 2018 Oct; 56():118-125. PubMed ID: 30173050
[TBL] [Abstract][Full Text] [Related]
10. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study.
Trudeau V; Larcher A; Boehm K; Dell'Oglio P; Sun M; Tian Z; Briganti A; Shariat SF; Jeldres C; Karakiewicz PI
Urology; 2016 Mar; 89():63-7. PubMed ID: 26514977
[TBL] [Abstract][Full Text] [Related]
12. Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy.
de Angelis M; Morra S; Scheipner L; Siech C; Jannello LMI; Baudo A; Goyal JA; Tian Z; Longo N; Ahyai S; de Cobelli O; Chun FKH; Saad F; Shariat SF; Carmignani L; Montorsi F; Briganti A; Karakiewicz PI
World J Urol; 2024 Mar; 42(1):193. PubMed ID: 38530480
[TBL] [Abstract][Full Text] [Related]
13. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.
Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ
Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794
[TBL] [Abstract][Full Text] [Related]
14. Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma.
Sorce G; Hoeh B; Hohenhorst L; Panunzio A; Tappero S; Tian Z; Kokorovic A; Larcher A; Capitanio U; Tilki D; Terrone C; Chun FKH; Antonelli A; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
J Urol; 2023 Jan; 209(1):81-88. PubMed ID: 36440817
[TBL] [Abstract][Full Text] [Related]
15. Population-based assessment of cancer-specific mortality after local tumour ablation or observation for kidney cancer: a competing risks analysis.
Larcher A; Trudeau V; Sun M; Boehm K; Meskawi M; Tian Z; Fossati N; Dell'Oglio P; Capitanio U; Briganti A; Shariat SF; Montorsi F; Karakiewicz PI
BJU Int; 2016 Oct; 118(4):541-6. PubMed ID: 26384713
[TBL] [Abstract][Full Text] [Related]
16. Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy.
Uhlig A; Hahn O; Strauss A; Lotz J; Trojan L; Müller-Wille R; Uhlig J
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):277-283. PubMed ID: 29075878
[TBL] [Abstract][Full Text] [Related]
17. Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis.
Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Urol Oncol; 2020 May; 38(5):506-514. PubMed ID: 32139292
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
19. Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer.
Larcher A; Sun M; Dell'Oglio P; Trudeau V; Boehm K; Schiffmann J; Tian Z; Fossati N; Capitanio U; Briganti A; Montorsi F; Karakiewicz P
Eur J Surg Oncol; 2017 Apr; 43(4):815-822. PubMed ID: 27692535
[TBL] [Abstract][Full Text] [Related]
20. Comparison of renal function detriments after local tumor ablation or partial nephrectomy for renal cell carcinoma.
Larcher A; Meskawi M; Valdivieso R; Boehm K; Trudeau V; Tian Z; Fossati N; Dell'Oglio P; Lughezzani G; Buffi N; Sun M; Karakiewicz P
World J Urol; 2016 Mar; 34(3):383-9. PubMed ID: 26047653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
